Expertise in
28
conditions

Dr. Shilpa Johri

Pulmonary Medicine | Intensive Care Medicine
Pulmonary Associates Of Richmond, Inc. (PAR)
Richmond, VA 
Accepting New Patients
Offers Telehealth
Referral may be required
Expertise in
28
conditions
Pulmonary Associates Of Richmond, Inc. (PAR)
Richmond, VA 

Overview

Shilpa Johri is a Pulmonary Medicine specialist and an Intensive Care Medicine provider practicing medicine in Richmond, Virginia.

Dr. Johri is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lung Metastases, and Interstitial Lung Disease.

Dr. Johri is board certified in (Internal Medicine, Critical Care Medicine), (Internal Medicine, Pulmonary Disease), and American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 6 clinical trials. Dr. Johri is currently accepting new patients.

Specialties

Pulmonary Medicine
Intensive Care Medicine

Licenses

Critical Care Medicine in VA

Board Certifications

(Internal Medicine, Critical Care Medicine)
(Internal Medicine, Pulmonary Disease)
American Board Of Internal Medicine

Fellowships

Weill Medical College Of Cornell University, Pulmonary And Critical Care Medicine - 2003

Hospital Affiliations

Medical College Of Virginia Hospitals
Bon Secours St Francis Medical Center
Henrico Doctors' Hospital
Bon Secours Memorial Regional Medical Center
Bon Secours St Marys Hospital
Bon Secours St. Francis Medical Center
Bon Secours Memorial Regional Medical Center
Bon Secours - St. Mary's Hospital

Languages Spoken

English
Hindi

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Pulmonary Associates of Richmond, Inc. (PAR)
Richmond, VA 23230

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept Versus Placebo for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Completed
Publish Date: April 15, 2026
Intervention Type: Drug
Study Drug: Sotatercept
Study Phase: Phase 2
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

7 Total Publications

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Journal: Respiratory medicine
Published: June 18, 2025
Similar Doctors
Expertise in
32
conditions
Dr. Michael A. Mistretta
Pulmonary Medicine | Intensive Care Medicine
Expertise in
32
conditions
Dr. Michael A. Mistretta
Pulmonary Medicine | Intensive Care Medicine
Referral may be required
Before you request

Pulmonary Associates Of Richmond, Inc. (PAR)

Richmond, VA 
 (1.7 miles away)
804-320-4243
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Mistretta is a Pulmonary Medicine specialist and an Intensive Care Medicine provider practicing medicine in Richmond, Virginia. Dr. Mistretta is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Asthma, Asthma in Children, Lung Metastases, and Chronic Obstructive Pulmonary Disease (COPD). Dr. Mistretta is board certified in (Internal Medicine, Critical Care Medicine), (Internal Medicine, Pulmonary Disease), and American Board Of Internal Medicine. Dr. Mistretta is currently accepting new patients.

Expertise in
39
conditions
Dr. Drew G. Jones-Iv
Pulmonary Medicine | Intensive Care Medicine
Expertise in
39
conditions
Dr. Drew G. Jones-Iv
Pulmonary Medicine | Intensive Care Medicine
Referral may be required
Before you request

Pulmonary Associates Of Richmond, Inc. (PAR)

7486 Right Flank Road, Suite 100, 
Mechanicsville, VA 
 (11.0 miles away)
804-320-4243
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Drew Jones-Iv is a Pulmonary Medicine specialist and an Intensive Care Medicine provider practicing medicine in Mechanicsville, Virginia. Dr. Jones-Iv is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Bronchiolitis Obliterans, Industrial Bronchitis, and Advanced Bronchoscopy. Dr. Jones-Iv is board certified in (Internal Medicine, Critical Care Medicine), (Internal Medicine, Pulmonary Disease), and American Board Of Internal Medicine. Dr. Jones-Iv is currently accepting new patients.

Expertise in
39
conditions
Dr. Johnny C. Wong
Pulmonary Medicine | Intensive Care Medicine
Expertise in
39
conditions
Dr. Johnny C. Wong
Pulmonary Medicine | Intensive Care Medicine
Referral may be required
Before you request

Pulmonary Associates Of Richmond, Inc. (PAR)

7486 Right Flank Road, Suite 100, 
Mechanicsville, VA 
 (11.0 miles away)
804-320-4243
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Johnny Wong is a Pulmonary Medicine specialist and an Intensive Care Medicine provider practicing medicine in Mechanicsville, Virginia. He has been practicing medicine for over 44 years. Dr. Wong is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, and Acute Interstitial Pneumonia. Dr. Wong is board certified in (Internal Medicine, Critical Care Medicine), (Pulmonary Disease), (Internal Medicine), American Board Of Internal Medicine, and (Sleep Medicine). Dr. Wong is currently accepting new patients.

Frequently Asked Questions about Dr. Shilpa Johri

How do I make an appointment with Dr. Shilpa Johri?

You can book an appointment with Dr. Shilpa Johri by calling their office at 804-320-4243. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shilpa Johri a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shilpa Johri is classified as an Distinguished expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shilpa Johri specialize in?

While Dr. Shilpa Johri is a Pulmonary Medicine, they have specific expertise in Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, and Lung Metastases. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Shilpa Johri participate in research or clinical trials?

Yes. Dr. Shilpa Johri has published 7 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Shilpa Johri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shilpa Johri accept my insurance?

Dr. Shilpa Johri accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 804-320-4243 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Johri's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 21 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile